VEGFA and non-small cell lung carcinoma: Initial experiments tested the ability of the VEGFq oligonucleotide to inhibit the growth of A549 NSCLC cells which overexpress VEGF. A549 cells were treated with VEGFq and MutVEGFq at concentrations of 5 and 10μM for 144 hours (Fig 1C).